openPR Logo
Press release

Dual Antiplatelet Therapy Market 2018: Share, Trends, Analysis, Market Drivers, Growth, Sales, Demand, Research, Opportunities, Future Roadmap, Value Chain, Ecosystem Player Profiles and Strategies, Survey and Industry Forecast to 2028

07-18-2018 03:55 PM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Dual Antiplatelet Therapy Market: Drivers and Restraints

The growing prevalence and recurrence of cardiac diseases is expected to be the major factor driving the growth of the dual antiplatelet therapy market over the forecast period. According to World Health Organization, cardiac disease is the number one cause of death globally. An estimated 17.2 million people die of cardiac diseases, representing 31% of global deaths, annually. Off the 17.2 million people, approximately 7.4 million people died due to coronary heart disease, whereas nearly 6.7 million died due to stroke. Changes in lifestyle and eating habits are attributed to the growing prevalence of cardiac diseases. Research & Development of antiplatelet therapies is another factor contributing to the growth of the global dual antiplatelet therapy market. However, costs associated and lack of awareness about dual antiplatelet therapy market are some of the factors restraining the growth of dual antiplatelet therapy market.

Dual Antiplatelet Therapy Market: Overview

The global market for dual antiplatelet therapy is expected to witness moderate growth over the forecast period. There is a high competition among local and regional players as majority of the antibiotics are introduced in the generic market. Among the two treatment types, the antibiotic treatment segment is expected to lead in the global dual antiplatelet therapy market over the forecast period. Retail pharmacy distribution channel is expected to contribute high share in the global dual antiplatelet therapy market as it is the most accessible channel and majority of the patients are recommended for outpatient treatment.

Dual Antiplatelet Therapy Market: Regional Outlook

Geographically, the global dual antiplatelet therapy market is segmented into viz. North America, Latin America, Europe, Asia Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be a dominant market in the global dual antiplatelet therapy market owing to high prevalence of the disease. The dual antiplatelet therapy market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to increasing prevalence of cardiac diseases. Europe is expected to have the second largest share in the global dual antiplatelet therapy market throughout the forecast period.

To know more about the Dual Antiplatelet Therapy Market Trends, Visit the link – https://www.factmr.com/report/1002/dual-antiplatelet-therapy-market

Dual Antiplatelet Therapy Market: Key Players

The global market for dual antiplatelet therapy is highly fragmented. Examples of some of the key players operating in the global dual antiplatelet therapy market are Bayer AG, Novacap, Shiono Chemical Co., Ltd., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Dr. Reddy's Laboratories, Eli Lilly & Co. Ltd. and others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional analysis includes

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Pre-book this Report- https://www.factmr.com/checkout/1002/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dual Antiplatelet Therapy Market 2018: Share, Trends, Analysis, Market Drivers, Growth, Sales, Demand, Research, Opportunities, Future Roadmap, Value Chain, Ecosystem Player Profiles and Strategies, Survey and Industry Forecast to 2028 here

News-ID: 1133672 • Views:

More Releases from Fact.MR

Intracranial Aneurysm Market is Expamding at a CAGR of 10.5% by 2035 |
09-19-2025 | Health & Medicine
Fact.MR
Intracranial Aneurysm Market is Expamding at a CAGR of 10.5% by 2035 |
The global intracranial aneurysm market is poised for robust growth over the next decade, as innovations in treatment techniques and a growing focus on early detection fuel demand. According to the latest market research, the industry is projected to expand at a strong CAGR of 10.5% during the forecast period from 2025 to 2035. This growth trajectory is expected to elevate the market value from USD 1,626 million in 2024
Airport Kiosk Market to Reach USD 5.67 Billion by 2033 | Avantor, Charter Medical, Colder Products Company, Cole Parmer, Corning, Danaher, Entegris
09-19-2025 | Health & Medicine
Fact.MR
Airport Kiosk Market to Reach USD 5.67 Billion by 2033 | Avantor, Charter Medica …
The global aviation industry is undergoing a massive transformation as airports increasingly turn to automation and digitalization to enhance passenger experience, reduce operational costs, and improve efficiency. Among the most visible symbols of this shift are airport kiosks, which are now integral to check-in, security, boarding, and baggage handling processes. According to the latest research, worldwide demand for airport kiosks is set to grow at a compound annual growth rate
Airport Kiosk Market to Reach USD 5.67 Billion by 2033 Driven by Automation in Air Travel
Airport Kiosk Market to Reach USD 5.67 Billion by 2033 Driven by Automation in A …
The global aviation industry is undergoing a massive transformation as airports increasingly turn to automation and digitalization to enhance passenger experience, reduce operational costs, and improve efficiency. Among the most visible symbols of this shift are airport kiosks, which are now integral to check-in, security, boarding, and baggage handling processes. According to the latest research, worldwide demand for airport kiosks is set to grow at a compound annual growth rate
Remote Control Market is Expanding at a CAGR of 4.8% by 2034 | Omni Remote; Zenith Electronics LLC,; Seoby Electronics; Cisco Systems
Remote Control Market is Expanding at a CAGR of 4.8% by 2034 | Omni Remote; Zeni …
The global remote control market is on a steady growth trajectory, underpinned by rapid technological advancements and the growing penetration of smart consumer electronics. According to the latest projections by Fact.MR, the market, valued at USD 26.4 billion in 2024, is expected to expand at a CAGR of 4.8% during the forecast period from 2024 to 2034, reaching USD 42.1 billion by the end of 2034. As households and industries

All 5 Releases


More Releases for Antiplatelet

Antiplatelet Market Analysis 2024: Size, Share & Growth Report 2032
Allied Market Research added new research on Antiplatelet Market- Global Opportunity Analysis and Industry Forecast, 2022-2032. The Antiplatelet market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon,
Antiplatelet Market To Witness Strong Growth by 2032 | Astrazeneca, Novartis, Pf …
Allied Market Research added new research on Antiplatelet Market- Global Opportunity Analysis and Industry Forecast, 2022-2032. The Antiplatelet market explores comprehensive study on various segments like size, share, development, innovation, sales and overall growth of major players. The research is based on primary and secondary data sources and it consists both qualitative and quantitative detailing. Some of the key players involved in the study are Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon,
Empowering Lives: Antiplatelet Drugs Market Trends
In 2023, the global antiplatelet drugs market reached an impressive value of USD 2.2 billion. This remarkable growth has been spurred by significant advancements in the pharmaceutical industry and a concerning increase in cases of thrombosis, which encompasses both arterial and venous conditions. As we look ahead to the forecast period of 2024-2032, the market is expected to continue its robust expansion, with a projected compound annual growth rate (CAGR)
Antiplatelet Market: Advancements in Preventing Blood Clotting Disorders
Allied Market Research Analyst have added a new research study on Title Antiplatelet Market, Global Outlook and Forecast 2023-2030 with detailed information & Key Players Such as Glaxosmithkline, Abbott Laboratories, Genentech, Armetheon Inc., Eli Lilly, Bayer AG, Daiichi Sankyo Co. Ltd., Merck, Johnson & Johnson, Novartis, and Pfizer Inc., F.Hoffmann-La Roche AG, Astrazeneca. The Study provides in-depth comprehensive analysis includes Clear Market definitions, classifications, manufacturing processes, cost structures, development policies
The Antiplatelet Drugs Market To Thrive Backed By Wearable Technology
Antiplatelet drugs are incorrectly referred to as blood thinners. They do not thin the blood, but interfere with the vital process by which the blood clots. Antiplatelet drugs usually reduce the aggregation of blood cells, reducing potentially harmful clots. Giving antiplatelet drugs to people at high risk of heart disease can help avoid the risk of stroke and heart attack . Get Sample Copy of This Report @
Antiplatelet Drugs Market - Increasing incidence of cardiovascular diseases is e …
The report presents an in-depth assessment of the Antiplatelet Drugs Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses of